Comparison of sunitinib (su) versus temsirolimus (tem) in patients (pts) with poor risk metastatic renal cell carcinoma (prmRCC)

Authors :: Victoria Neiman
Daniel Keizman
Avishay Sella
Eli Rosenbaum
Maya Gottfried
Natalie Maimon
David Sarid
Eli Gez
Michael Anthony Carducci
Hans J. Hammers
Mario A. Eisenberger
Victoria J. Sinibaldi
Avivit Peer
Avivit Neumann
Svetlana Kovel
Wilmosh Mermershtain
Keren Rouvinov
Ilan Feldhamer
Raanan Berger
Ariel Hammerman
Source :: Journal of Clinical Oncology. 34:e16090-e16090
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.

Tools